Indirect economic burden of sickle cell disease D Holdford, N Vendetti, DM Sop, S Johnson, WR Smith Value in Health 24 (8), 1095-1101, 2021 | 28 | 2021 |
A randomised controlled provider‐blinded trial of community health workers in sickle cell anaemia: effects on haematologic variables and hydroxyurea adherence WR Smith, DK McClish, R Lottenberg, IY Sisler, D Sop, S Johnson, ... British Journal of Haematology 196 (1), 193-203, 2022 | 6 | 2022 |
Survey of physician perspective towards management of pain for chronic conditions in the emergency department D Sop, W Smith, A Alsalman, JL Wong, DY Fei, D McClish, A Rafiq, ... Modern clinical medicine research 1 (3), 55, 2017 | 5 | 2017 |
Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease DM Sop, T Crouch, Y Zhang, T Lipato, J Wilson, WR Smith Healthcare 10 (8), 1506, 2022 | 2 | 2022 |
Using lean six sigma to develop a patient centered medical home for adults with sickle cell disease S Johnson, S Hartigan, E Holt, D Sop, C McHenry, T Lipato, T Elliott, ... Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 2 | 2019 |
COVID symptoms and COVID anxiety in sickle cell disease WR Smith, B Jaworowski, S Johnson, T Lipato, DM Sop Blood 136, 16-17, 2020 | 1 | 2020 |
The effect of patient navigators on health-related quality of life in sickle cell anemia: the SHIP-HU study WR Smith, D k McClish, S Johnson, R Lottenberg, D Sop, A Villella, ... Blood 134, 2168, 2019 | 1 | 2019 |
Responsivity of Utilization Rates to the Intensity of Case Management over Time Among High-Utilizing Adults with Sickle Cell Disease WR Smith, D Sop, S Johnson, T Lipato, S Hartigan Blood 134, 5803, 2019 | 1 | 2019 |
The effect of patient navigators on laboratory parameters of hydroxyurea adherence in sickle cell anemia: the ship-hu study WR Smith, D k McClish, R Lottenberg, D Sop, S Johnson, A Villella, ... Blood 134, 2309, 2019 | 1 | 2019 |
The association of painful crises with patient reported outcomes in sickle cell disease: the SHIP-HU study D k McClish, WR Smith, V Okhomiuna, DS Mouaffo, R Lottenberg, I Chen, ... Blood 132, 3509, 2018 | 1 | 2018 |
Comparison of adult and adolescent quality of ambulatory and emergency care in sickle cell disease: ASCQ-Me and the SHIP-HU study WR Smith, D k McClish, R Lottenberg, I Chen, MJ Treadwell, S Keller, ... Blood 130, 2258, 2017 | 1 | 2017 |
Incidence, Prevalence, and Disease Management Impactability of High Utilization in an Adult Sickle Cell Medical Home WR Smith, D Sop, YM Zhang, B Jaworowski, S Johnson Blood 142, 7206, 2023 | | 2023 |
Towards an Implicit Measure of Patient Engagement in Sickle Cell Disease: Relationships between Implicit Measures of Engagement and Previous Childhood Trauma Among Adolescents … H Hartzog, S Johnson, R Walls, YM Zhang, D Sop, WR Smith Blood 142, 7319, 2023 | | 2023 |
Component-Specific Effects of Team Case Management on Adult Sickle Cell Utilization in Moderate to Low Utilizers S Johnson, D Sop, A Hardy, R Walls, YM Zhang, B Jaworowski, WR Smith Blood 142, 7197, 2023 | | 2023 |
Relative Influence of Biological Versus Behavioral Determinants of Utilization Among Adults with Sickle Cell Disease M Ferlis, D Sop, YM Zhang, WR Smith Blood 142, 3680, 2023 | | 2023 |
Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease WS Daniel Sop, Joel L Steinberg, Jennifer Jordan, Taylor Crouch, Yue May Zhang Journal of Neurology and Experimental Neural Science 5 (01), 2023 | | 2023 |
Intensive Case Management in an Adult Sickle Cell Medical Home: Annual Effects on Utilization Efficiency Using Community Health Workers S Johnson, DM Sop, YM Zhang, B Jaworowski, WR Smith Blood 140 (Supplement 1), 1625-1626, 2022 | | 2022 |
Inpatient Reliance Ratio Versus Emergency Department Reliance Ratio in a Sickle Cell Disease Medical Home DM Sop, YM Zhang, S Johnson, B Jaworowski, WR Smith Blood 140 (Supplement 1), 7881-7882, 2022 | | 2022 |
Sickle Cell Disease May Qualify As an Ambulatory Care Sensitive Condition WR Smith, YM Zhang, S Johnson, DM Sop Blood 140 (Supplement 1), 7862-7863, 2022 | | 2022 |
Screening for Adverse Childhood Experiences (ACEs) As a Way to Predict Overdose Risk in Adult Sickle Cell Patients R Walls, DM Sop, YM Zhang, B Jaworowski, S Johnson, WR Smith Blood 140 (Supplement 1), 13039-13040, 2022 | | 2022 |